These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27708583)

  • 1. Preparation and Characterization of Loperamide-Loaded Dynasan 114 Solid Lipid Nanoparticles for Increased Oral Absorption In the Treatment of Diarrhea.
    Wei L; Yang Y; Shi K; Wu J; Zhao W; Mo J
    Front Pharmacol; 2016; 7():332. PubMed ID: 27708583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.
    Dudhipala N; Veerabrahma K
    Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats.
    Ansari MJ; Anwer MK; Jamil S; Al-Shdefat R; Ali BE; Ahmad MM; Ansari MN
    Drug Deliv; 2016 Jul; 23(6):1972-9. PubMed ID: 26017100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and stability of nanostructured lipid carriers as drug delivery system.
    Abbasalipourkabir R; Salehzadeh A; Abdullah R
    Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential enhancement of metformin hydrochloride in solidified reverse micellar solution-based PEGylated lipid nanoparticles targeting therapeutic efficacy in diabetes treatment.
    Kenechukwu FC; Nnamani DO; Duhu JC; Nmesirionye BU; Momoh MA; Akpa PA; Attama AA
    Heliyon; 2022 Mar; 8(3):e09099. PubMed ID: 35309393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
    Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
    Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
    Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH
    Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, Characterization and Pharmacokinetics of Tolfenamic Acid-Loaded Solid Lipid Nanoparticles.
    Xu W; Deng Z; Xiang Y; Zhu D; Yi D; Mo Y; Liu Y; Qin L; Huang L; Wan B; Wu L; Feng X; He J
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery.
    Chen X; Peng LH; Shan YH; Li N; Wei W; Yu L; Li QM; Liang WQ; Gao JQ
    Int J Pharm; 2013 Apr; 447(1-2):171-81. PubMed ID: 23500766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Optimization of Mirabegron Solid Lipid Nanoparticles as an Oral Drug Delivery for Overactive Bladder.
    Raut P; Gambhire M; Panchal D; Gambhire V
    Pharm Nanotechnol; 2021; 9(2):120-129. PubMed ID: 33504321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, in vitro and in vivo Evaluation of Thermosensitive in situ Gel Loaded with Ibuprofen-Solid Lipid Nanoparticles for Rectal Delivery.
    Huang CH; Hu PY; Wu QY; Xia MY; Zhang WL; Lei ZQ; Li DX; Zhang GS; Feng JF
    Drug Des Devel Ther; 2022; 16():1407-1431. PubMed ID: 35586185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nanoparticles.
    Jia Y; Ji J; Wang F; Shi L; Yu J; Wang D
    Drug Deliv; 2016 May; 23(4):1317-25. PubMed ID: 25371296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray-dried Solid Lipid Nanoparticles for Enhancing Berberine Bioavailability
    Nguyen VH; Le KNM; Nguyen MCN
    Curr Pharm Des; 2023; 29(38):3050-3059. PubMed ID: 37961862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and
    Dudhipala N; Ettireddy S; Youssef AAA; Puchchakayala G
    Nanotheranostics; 2023; 7(1):117-127. PubMed ID: 36593793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.